What Cure Kids Ventures does

Cure Kids Ventures is a New Zealand-based venture capital firm and a wholly owned subsidiary of Cure Kids, founded in 2008 and operating with 1-10 employees from Auckland. The firm invests across research, seed, early-stage, and expansion rounds, with a stated thematic focus on medtech and healthtech ventures addressing pediatric health, critical care, and medical device innovation. Its stated differentiator is targeted capital paired with domain expertise in children's health, supporting portfolio companies through clinical validation and regulatory pathways.

The firm's only visible recent strategic action is co-investment in Wellumio's NZ$7.28 million (approximately US$4.3 million) pre-Series A round in February 2026, led by Nuance Connected Capital with co-investors Icehouse Ventures, NZ Growth Capital Partners, Pacific Channel, and Booster. Wellumio is developing the Axana portable MRI system for rapid bedside stroke diagnosis, an investment that illustrates the firm's orientation toward acute care diagnostics adjacent to its pediatric mandate.

As a VC entity wholly owned by Cure Kids, the firm's revenue mechanics derive from management fees and any carried interest on portfolio exits, neither of which are disclosed in the source material. No pricing, fund size, LP base, or portfolio composition is publicly available. The firm reports no products, patents, certifications, or AI/ML capabilities of its own; its intellectual property is selection capability and Cure Kids' clinical research network.

Name

Cure Kids Ventures

Website

https://curekidsventures.co.nz

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Cure Kids Ventures is a New Zealand-based venture capital firm and wholly owned subsidiary of Cure Kids, investing seed-to-expansion capital in medtech and healthtech startups focused on pediatric health, critical care, and medical devices.

Ownership category

akta.pro rank

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

Cure Kids Ventures is a New Zealand-based venture capital firm that provides seed, early-stage, and expansion-stage funding to medtech and health technology companies focused on pediatric health, critical care, and medical devices. As a wholly owned subsidiary of Cure Kids, the firm invests in research-driven ventures developing solutions for children's health and acute medical conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Early-Stage Medtech Venture Capital Investments

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• Pacific Channel: NZ-based VC investing in deep tech and health technology, co-invested with Cure Kids Ventures in Wellumio. Directly comparable as a fellow NZ deep-tech/health-focused investor.
• Icehouse Ventures: New Zealand-based early-stage VC firm that co-invested alongside Cure Kids Ventures in Wellumio's pre-Series A round. Highly comparable given shared NZ geography, early-stage mandate, and overlapping investor syndicates.
• Nuance Connected Capital: NZ VC specializing in connected health and medical technology; led the Wellumio round in which Cure Kids Ventures participated. Closest direct peer given overlapping focus on connected/medtech health investments in the same geography.
• NZ Growth Capital Partners: NZ-focused growth-stage investor that co-invested with Cure Kids Ventures in Wellumio. Comparable as a fellow NZ institutional VC active in the same syndicated deals.
• Movac: One of New Zealand's largest and most active early-stage VC funds with deep tech and health tech exposure. Direct peer given similar NZ geography, early-stage mandate, and overlapping tech/health thesis.
• Global From Day One (GD1): NZ-based early-stage VC fund that invests from seed to Series A across tech verticals including health. Comparable peer given shared geography and stage focus.
• BioPacific Partners: Australasia-focused venture investor specializing in life sciences and biotech including medical devices. Direct comparable given similar stage focus and health-tech mandate across the trans-Tasman region.

Broad incumbents

• Brandon Capital: Australasia's largest dedicated life sciences VC manager, operating the Medical Research Commercialisation Fund. Broader incumbent in the same health-tech investment category but at much greater scale and geographic reach.
• OneVentures: Australian healthcare and technology VC firm with funds dedicated to life sciences and medtech. Comparable as a regional healthtech investor with deeper pockets than Cure Kids Ventures.

Others

• Cure Kids (parent foundation): The wholly-owning parent charitable foundation of Cure Kids Ventures, funding pediatric medical research in NZ. Listed as an "other" because, while not a peer investor, it is the structural counterparty that defines the firm's mandate and capital base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cure-kids-ventures

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments18 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cure Kids Ventures